lifesciencelaw.ch

 

Federal Administrative Court, Decision 6595/2018 of 8 June 2020

25. June 2020 – In a recent decision, the Federal Administrative Court held that in exceptional cases, a therapeutic cross comparison (TQV) can be waived if suitable reference products are not available. The appeal is dismissed. For the full decision, see here.